| scholarly article | Q13442814 |
| P2093 | author name string | Jerry Frank | |
| Kenneth R Cohen | |||
| Igor Israel | |||
| Rebecca L Salbu | |||
| P2860 | cites work | Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine | Q81145506 |
| Skin findings in thyroid diseases | Q83572107 | ||
| The effect of topically applied aspirin on localized circumscribed neurodermatitis | Q28191659 | ||
| Itch: scratching more than the surface | Q28194545 | ||
| Itch: a symptom of occult disease | Q28276241 | ||
| A survey of skin problems and skin care regimens in the elderly | Q28303004 | ||
| Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group | Q28307784 | ||
| Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia | Q28374767 | ||
| The pruritus of cholestasis | Q33545718 | ||
| Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy | Q33556752 | ||
| The diagnostic and therapeutic approach to idiopathic generalized pruritus | Q33815789 | ||
| Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. | Q33905243 | ||
| Cutaneous manifestations of end-stage renal disease | Q34095002 | ||
| Polycythemia vera-associated pruritus and its management | Q34123884 | ||
| Itch and pruritus: what are they, and how should itches be classified? | Q34468701 | ||
| Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions | Q34500071 | ||
| Drug-induced skin, nail and hair disorders | Q34708125 | ||
| Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). | Q34734120 | ||
| Skin reactions to antibacterial agents in general practice | Q34752826 | ||
| Pruritus of polycythaemia vera: a place for pizotifen? | Q34781931 | ||
| Mechanism of action of antipruritic drugs | Q34995487 | ||
| Scabies and pyodermas--diagnosis and treatment | Q35011254 | ||
| Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies | Q35063685 | ||
| Review article: pruritus in cholestatic and other liver diseases | Q35091959 | ||
| Treatment of pruritic diseases with topical calcineurin inhibitors. | Q35166799 | ||
| Drug eruptions: approaching the diagnosis of drug-induced skin diseases | Q35171419 | ||
| Pruritus: a practical approach | Q35258431 | ||
| Xerosis and pruritus in the elderly: recognition and management | Q35544168 | ||
| Neurophysiology of pruritus: cutaneous elicitation of itch | Q35586898 | ||
| Clinicopathologic attributes of common geriatric dermatologic entities | Q35689720 | ||
| Uremic pruritus: a review. | Q36271104 | ||
| Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity | Q36284579 | ||
| Neuroanatomy and neurophysiology of itch | Q36317054 | ||
| Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure | Q36530284 | ||
| Management of common opioid-induced adverse effects. | Q36646115 | ||
| The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis | Q36798178 | ||
| Menthol: a refreshing look at this ancient compound | Q36820432 | ||
| Neurophysiological and neurochemical basis of modern pruritus treatment. | Q37028291 | ||
| Functional and physiological characteristics of the aging skin | Q37204697 | ||
| Pathogenesis and treatment of pruritus in cholestasis | Q37288746 | ||
| Clinical implications of aging skin: cutaneous disorders in the elderly | Q37394774 | ||
| Drug-induced pruritus: a review | Q37499989 | ||
| Useful tools for the management of atopic dermatitis. | Q37573703 | ||
| Opioid-induced pruritus: an update. | Q37575834 | ||
| Therapeutic and experimental therapeutic studies on acupuncture and itch: review of the literature | Q37718914 | ||
| Therapy of pruritus | Q37738911 | ||
| Topical capsaicin. The fire of a 'hot' medicine is reignited | Q37743506 | ||
| Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study | Q78554315 | ||
| Pruritus | Q79112531 | ||
| The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients | Q79780030 | ||
| Generalized pruritus treated with narrowband UVB | Q80176449 | ||
| Generalized pruritus: a prospective study concerning etiology | Q80231773 | ||
| Antipruritic treatment with systemic μ-opioid receptor antagonists: a review | Q37749941 | ||
| The management of chronic pruritus in the elderly | Q37789167 | ||
| Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy | Q37792034 | ||
| Topical preparations for pain relief: efficacy and patient adherence | Q37851017 | ||
| Mediators of pruritus during cholestasis. | Q37859604 | ||
| A diagnostic approach to pruritus. | Q37902173 | ||
| Approach to pruritus in the adult HIV-positive patient | Q37902320 | ||
| Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study | Q38390926 | ||
| Seasonal influences on stratum corneum ceramide 1 fatty acids and the influence of topical essential fatty acids | Q39277967 | ||
| Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. | Q39355978 | ||
| The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group | Q39470353 | ||
| The molecular mechanism of cholestatic pruritus. | Q39521008 | ||
| Pathophysiology of pruritus | Q39538888 | ||
| Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study | Q39692850 | ||
| Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. | Q40004812 | ||
| Skin xerosis. Clinical report on the effect of a moisturizing soap bar | Q40887865 | ||
| Pathophysiology of itching | Q40923361 | ||
| Superficial dorsal horn neurons identified by intracutaneous histamine: chemonociceptive responses and modulation by morphine | Q41754614 | ||
| Pruritus: an updated look at an old problem | Q42531484 | ||
| Butorphanol for treatment of intractable pruritus | Q42680770 | ||
| Pruritus: control of itch in patients undergoing dialysis | Q43111296 | ||
| Are itch and chronic pain associated in adults? Results of a large population survey in Norway | Q43674442 | ||
| Neuromediators--a crucial component of the skin immune system | Q44203110 | ||
| Mirtazapine for pruritus | Q44340894 | ||
| Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study | Q44903581 | ||
| Gabapentin and uremic pruritus in hemodialysis patients | Q46124053 | ||
| A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients | Q46343813 | ||
| Pregabalin in the treatment of chronic pruritus. | Q46810840 | ||
| Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study | Q46832897 | ||
| Efficacy of gabapentin in the management of pruritus of unknown origin | Q46859498 | ||
| Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy | Q46933569 | ||
| The impact of pruritus on quality of life: the skin equivalent of pain. | Q48647840 | ||
| Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. | Q51911492 | ||
| Scabies | Q54093015 | ||
| Itch: role of prostaglandins. | Q55043530 | ||
| Clinical Classification of Itch: a Position Paper of the International Forum for the Study of Itch | Q60678276 | ||
| French People and Skin Diseases | Q61908710 | ||
| Pruritus in the elderly | Q62073523 | ||
| Skin changes of aging: pathological implications | Q68931743 | ||
| Diseases of the skin. The management of pruritus | Q70041207 | ||
| Letter: Post-herpetic pruritus | Q70051718 | ||
| Unilateral neurogenic pruritus following stroke | Q70602820 | ||
| Changes with age in the moisture content of human skin | Q71251925 | ||
| Stratum corneum lipids: the effect of ageing and the seasons | Q71848364 | ||
| Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin | Q73382269 | ||
| Adult-onset recalcitrant eczema: a marker of noncutaneous lymphoma or leukemia | Q74038741 | ||
| Poststroke pruritus | Q74583767 | ||
| P433 | issue | 4 | |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 227-239 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | P & T: journal for formulary management | Q15767306 |
| P1476 | title | Pruritus in the elderly: clinical approaches to the improvement of quality of life | |
| P478 | volume | 37 |
| Q59471811 | Peripheral nerve block with a high concentration of tetracaine dissolved in bupivacaine for intractable post-herpetic itch: a case report | cites work | P2860 |
Search more.